Therapeutic control of blood pressure, cholesterol and glucose by gender
| Male (n=903) | Female (n=274) | P value | |||
| n | % (95% CI) | n | % (95% CI) | ||
| Blood pressure* | 899 | 258 | |||
| BP at target 1† | 595 | 69.9 (66.7 to 73.0) | 187 | 72.4 (66.6 to 77.8) | 0.43 |
| BP at target 2‡ | 360 | 42.3 (39.0 to 45.7) | 119 | 46.1 (39.9 to 52.4) | 0.28 |
| Cholesterol§ | 759 | 219 | |||
| TC <5.0 mmol/L | 698 | 92.0 (89.8 to 93.8) | 184 | 84.0 (78.5 to 88.6) | <0.001 |
| TC <4.0 mmol/L | 523 | 68.9 (65.4 to 72.2) | 104 | 47.5 (40.7 to 54.3) | <0.001 |
| LDL <1.8 mmol/L¶ | 329 | 43.9 (40.3 to 47.6) | 75 | 34.7 (28.4 to 41.5) | 0.02 |
| LDL <2.0 mmol/L¶ | 441 | 58.9 (55.3 to 62.4) | 93 | 43.1 (36.4 to 49.9) | <0.001 |
| LDL <3.0 mmol/L¶ | 695 | 92.8 (90.7 to 94.5) | 193 | 89.4 (84.5 to 93.1) | 0.10 |
| Non-HDL <2.5 mmol/L | 400 | 52.7 (49.1 to 56.3) | 89 | 40.6 (34.1 to 47.4) | 0.002 |
| Glucose and BP control in diabetics** | 209 | 58 | |||
| Glucose <7 mmol/L†† | 61 | 30.4 (24.1 to 37.2) | 16 | 29.1 (17.6 to 42.9) | 0.86 |
| HbA1c <7% (<53 mmol/mol)‡‡ | 107 | 54.9 (47.6 to 62.0) | 29 | 50.0 (36.6 to 63.4) | 0.51 |
| HbA1c <6% (<42 mmol/mol)‡‡ | 29 | 14.9 (10.2 to 20.7) | 9 | 15.5 (7.3 to 27.4) | 0.90 |
| BP at target‡ | 81 | 38.8 (32.1 to 45.7) | 25 | 43.1 (30.2 to 56.8) | 0.55 |
p values in bold indicate those with statistical significance
*Figures for those on blood pressure-lowering medication.
†Defined as blood pressure <140/90 mm Hg.
‡Defined as blood pressure <130/80 mm Hg.
§Figures for those on lipid-lowering medication and with cholesterol measurements made.
¶Data available for 749 male and 216 female patients.
**Figures for self-reported diabetics only.
††Data available for 201 male patients, 55 female.
‡‡Data available for 195 male patients, 58 female.
BP, blood pressure; HDL, high-density lipoprotein; LDL, high-density lipoprotein; TC, total cholesterol.